AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 49 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $177,000 | -1.7% | 27,073 | 0.0% | 0.00% | – |
| Q2 2021 | $180,000 | -8.6% | 27,073 | -21.1% | 0.00% | – |
| Q1 2021 | $197,000 | -35.8% | 34,323 | 0.0% | 0.00% | – |
| Q4 2020 | $307,000 | -24.8% | 34,323 | -2.0% | 0.00% | – |
| Q3 2020 | $408,000 | -8.9% | 35,023 | +25.4% | 0.00% | -100.0% |
| Q2 2020 | $448,000 | +209.0% | 27,923 | +15.3% | 0.00% | – |
| Q1 2020 | $145,000 | -54.1% | 24,223 | +1.3% | 0.00% | – |
| Q4 2019 | $316,000 | +6.4% | 23,912 | 0.0% | 0.00% | – |
| Q3 2019 | $297,000 | -8.0% | 23,912 | +19.2% | 0.00% | – |
| Q2 2019 | $323,000 | +61.5% | 20,062 | +215.3% | 0.00% | – |
| Q1 2019 | $200,000 | -10.7% | 6,362 | -6.6% | 0.00% | – |
| Q4 2018 | $224,000 | +4.7% | 6,812 | -4.2% | 0.00% | – |
| Q3 2018 | $214,000 | +12.0% | 7,112 | 0.0% | 0.00% | – |
| Q2 2018 | $191,000 | – | 7,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |